CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 10 enrolled
Drug / intervention
Bleomycin Sulfate +4 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03596918
NCT03596918N/ACompleted
CompareCT.gov

Longitudinal Quality of Life Study Among Participants With AIDS-Associated Kaposi Sarcoma at Bugando Medical Centre, in Mwanza, Tanzania

AIDS Malignancy Consortium·observational·Posted Jul 24, 2018·Updated Feb 11, 2026

In Brief

An observational study evaluating Bleomycin Sulfate, Laboratory Biomarker Analysis, and 3 other interventions for AIDS-Related Kaposi Sarcoma and Human Immunodeficiency Virus 1 Positive. Completed, enrolled 10 participants across 1 site.

Detailed Summary

This pilot phase I trial studies how well treatment with vincristine and bleomycin affect quality of life in patients with acquired immunodeficiency syndrome (AIDS)-associated Kaposi sarcoma.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAIDS-Related Kaposi Sarcoma, Human Immunodeficiency Virus 1 Positive
CountriesTanzania
CollaboratorsNational Cancer Institute (NCI), The Emmes Company, LLC, University of Arkansas, University of California, Los Angeles

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJul 24, 2018
Enrollment StartOct 10, 2018
Primary CompletionJun 13, 2020
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 7.9 years ago

Interventions

Bleomycin Sulfatebiological

Given IV

Laboratory Biomarker Analysisother

Correlative studies

Quality-of-Life Assessmentother

Ancillary studies

Questionnaire Administrationother

Ancillary studies

Vincristine Sulfatedrug

Given IV